Ciclosporin - Allergic conjunctivitis
You are here : Home > Formulary Search > Ciclosporin - Allergic conjunctivitis
Status 1
- Eye drops (unit dose)
0.1% ciclosporin (Verkazia)
Prescribe by brand for Vernal Keratoconjunctivitis (VKC) to ensure licensed product for this indication is dispensed.
The specialist team will initiate and prescribe for at least 3 months until the VKC is stabilised, prior to transfer of care
Documentation
PAD Profile
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed to add Verkazia® (ciclosporin 1mg/mL eye drops) for the treatment of Vernal Keratoconjunctivitis (VKC) to the Joint Formulary for children aged over 4 and adolescents.
Verkazia® (ciclosporin 1mg/mL eye drops) single unit dose vials should be prescribed by brand for VKC to ensure the patient is dispensed the ciclosporin preparation licensed for this indication.
A BLUE (with specialist team initiation) traffic light status was agreed with the specialists prescribing for 3 months or until the patients condition is stabilised, prior to transfer of care
Other Indications
Below are listed other indications that Ciclosporin is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Allergic conjunctivitis.